GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.19; Lowers FY14 EPS Growth Outlook

GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of GBP0.19, versus GBP0.26 reported last year. Revenue for the quarter came in at GBP5.56 billion, versus GBP6.62 billion reported last year.

Full year 2014 core EPS now expected to be broadly similar to 2013, from prior growth expectations of 4 to 8 percent.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance
• StubHub Holdings, Inc. (STUB) Misses Q2 EPS by 24c
• Jack in the Box (JACK) Tops Q3 EPS by 6c; offers outlook